Mélotte Medica SRL
Mélotte Medica reported total assets of 179,447 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jun 2026).
The score of Mélotte Medica shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets -18 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mélotte Medica's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 40,001 € | ||||
| Equity | 20,460 € | ||||
| Cash | 27,884 € | ||||
| EBITDA | 86,799 € | ||||
| Total assets | 179,447 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jun 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 25 Aug 2022
Mélotte Medica's financial analysis
- Solvency11.4%sector median: 65.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mélotte Medica
Mélotte Medica's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0699.762.156
- VAT number
- BE0699762156
- Peppol
- Registered · 0208:0699762156 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Jul 2018
- Registered office
- 4210 Burdinne
- Latest accounts
- 2025 · filed on 01 Jun 2026
- Activity
- General medical practice activities (NACE 86210)
Mélotte Medica (SRL) has been based in Burdinne since 2018, active in: general medical practice activities. For 2025, it reports a net profit of 40,001 € and equity of 20,460 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Mélotte Medica
Companies in the same business, of comparable size and area, outside its group.
- Dr Maude Kasel General medical practice activities Uccle · balance sheet 179,390 €
- Dr. TIJSKENS Rafaëla General medical practice activities Lummen · balance sheet 179,509 €
- DR.Nishio.Shunji General medical practice activities Hoeilaart · balance sheet 179,681 €
- Dokter Maaike de Graag General medical practice activities Schoten · balance sheet 179,170 €
- SRL Pascale Dusart, Medecine Generale General medical practice activities Musson · balance sheet 179,145 €
- Wilmsen Jens General medical practice activities Oud-Turnhout · balance sheet 179,822 €
- Dr. Alexander Schuermans Huisarts General medical practice activities Tervuren · balance sheet 178,917 €
- Thunnus General medical practice activities De Haan · balance sheet 180,193 €
Frequently asked questions about Mélotte Medica
What is the revenue of Mélotte Medica?
Mélotte Medica files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mélotte Medica?
In Belgium, the VAT number is the company number prefixed with BE: BE0699762156 for Mélotte Medica, if the company is VAT-registered. Its company number (CBE) is 0699.762.156.
Where is the registered office of Mélotte Medica?
According to the CBE register, the registered office of Mélotte Medica is in 4210 Burdinne.
What is the equity of Mélotte Medica?
At the close of the 2025 financial year, the equity of Mélotte Medica amounts to 20,460 €, a solvency of 11.4% of total assets.
Who manages Mélotte Medica?
The register lists 1 active mandates at Mélotte Medica. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mélotte Medica
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →